Clobetasol Propionate + Salicylic Acid: Brands, Price & Uses in Bangladesh

Clobetasol Propionate + Salicylic Acid ointment is a topical combination of a super-potent (Class I) corticosteroid and a keratolytic agent, indicated for:

Established use

• Short-term topical treatment of moderate-to-severe, thick, or hyperkeratotic (scaly) plaque psoriasis in adults, particularly localized plaques on the trunk, limbs, and scalp that are resistant to standard corticosteroid-only therapy.

Guideline-supported / adjunct use

• As an adjunct in scalp psoriasis, where the keratolytic action of salicylic acid helps soften and remove thick scale, improving penetration of clobetasol propionate into the affected skin.
• For other chronic, recalcitrant, corticosteroid-responsive hyperkeratotic dermatoses (e.g., lichen simplex chronicus, discoid lupus erythematosus lesions with thick scale) at the discretion of the prescribing physician, when standard therapy is inadequate.

Clobetasol Propionate + Salicylic Acid is intended for short-term, localized use only and is not a first-line treatment for mild psoriasis or for widespread/extensive disease.

Adult dosage

Pediatric dosage

Not recommended for use in children under 12 years of age; safety and efficacy in this age group have not been established. Use in adolescents (12-17 years) only under close physician supervision, for the shortest duration and smallest area necessary, due to greater risk of systemic absorption of both components relative to body surface area.

Renal/hepatic impairment

No specific dose adjustment is established for topical use; however, caution is advised because reduced clearance of systemically absorbed corticosteroid or salicylate could theoretically increase risk of systemic effects in significant hepatic or renal impairment.

General instructions

• Apply only to the affected psoriatic plaques; avoid normal surrounding skin where possible.
• Do not use on the face, groin, axillae, or other skin folds unless specifically directed by the physician, as these thin-skin areas are more prone to atrophy.
• Do not apply under occlusive dressings/bandages unless specifically instructed.
• Do not exceed the maximum body surface area, dose, or duration prescribed, to minimize risk of HPA-axis suppression and salicylate absorption.

Local skin reactions are most common; systemic effects are uncommon with correct short-term, limited-area use but risk rises with excessive quantity, duration, or body surface area.

Common

• Burning, stinging, or irritation at the application site (more often due to the salicylic acid component)
• Dryness, itching, or mild redness

Less common but significant

• Skin atrophy, striae (stretch marks), and telangiectasia (visible small blood vessels) with prolonged/excessive use
• Folliculitis, hypertrichosis, perioral dermatitis, and hypopigmentation at the treated site
• Allergic contact dermatitis

Rare but serious

• Hypothalamic-pituitary-adrenal (HPA) axis suppression, Cushingoid features, or hyperglycemia, with excessive/prolonged use or use over large body surface areas
• Salicylate toxicity (salicylism) - tinnitus, dizziness, nausea, vomiting, hyperventilation, or metabolic disturbance - with excessive systemic absorption of the salicylic acid component (see Overdose)